2021 Q2 Form 10-Q Financial Statement

#000110465921102860 Filed on August 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q4
Revenue $162.6M $61.86M $92.32M
YoY Change -17.19%
Cost Of Revenue $1.700M $1.600M $1.300M
YoY Change 112.5% 77.78%
Gross Profit $76.70M $82.60M $91.00M
YoY Change 26.78% 12.08%
Gross Profit Margin 47.16% 133.53% 98.57%
Selling, General & Admin $67.65M $9.397M $40.23M
YoY Change -44.4%
% of Gross Profit 88.2% 11.38% 44.21%
Research & Development $2.700M
YoY Change
% of Gross Profit 3.27%
Depreciation & Amortization $4.577M $2.164M $1.957M
YoY Change 52.57% 54.57%
% of Gross Profit 5.97% 2.62% 2.15%
Operating Expenses $75.57M $12.10M $71.52M
YoY Change -76.0%
Operating Profit -$543.6K $24.38M $19.48M
YoY Change -100.9% 4.65%
Interest Expense -$43.53M -$26.48M -$4.154M
YoY Change 706.02% 307.32%
% of Operating Profit -108.58% -21.32%
Other Income/Expense, Net -$15.72M -$521.0K -$493.7K
YoY Change
Pretax Income $42.37M $24.38M $16.16M
YoY Change 44.28%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$16.26M -$3.086M $16.16M
YoY Change -118.26%
Net Earnings / Revenue -10.0% -4.99% 17.5%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $221.7K $146.9K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.25M $575.4K $1.138M
YoY Change
Cash & Equivalents $311.2K $95.97M $25.60M
Short-Term Investments
Other Short-Term Assets $212.5K $228.5K
YoY Change
Inventory
Prepaid Expenses $116.7K $228.5K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $428.0K $787.9K $1.366M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.56M $10.56M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $243.4M $243.4M
YoY Change
Other Assets $65.53M
YoY Change
Total Long-Term Assets $243.4M $243.4M $284.5M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $428.0K $787.9K $1.366M
Total Long-Term Assets $243.4M $243.4M $284.5M
Total Assets $243.8M $244.2M $285.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.540M $1.368M $135.6K
YoY Change
Accrued Expenses $28.62M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.540M $1.368M $135.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $230.6M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $23.72M $22.44M
YoY Change
Total Long-Term Liabilities $230.6M $23.72M $22.44M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.540M $1.368M $135.6K
Total Long-Term Liabilities $230.6M $23.72M $22.44M
Total Liabilities $40.98M $25.09M $186.5M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$27.39M $92.32M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M $5.000M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $243.8M $244.2M $285.8M
YoY Change

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$16.26M -$3.086M $16.16M
YoY Change -118.26%
Depreciation, Depletion And Amortization $4.577M $2.164M $1.957M
YoY Change 52.57% 54.57%
Cash From Operating Activities $85.39M $45.36M $48.69M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$6.581M -$2.589M
YoY Change -215.46%
Acquisitions
YoY Change
Other Investing Activities -$41.29M -$6.000K -$52.07M
YoY Change 1964.55%
Cash From Investing Activities -$47.87M -$4.642M -$54.66M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 38.16M $9.594M 7.408M
YoY Change
NET CHANGE
Cash From Operating Activities 85.39M $45.36M 48.69M
Cash From Investing Activities -47.87M -$4.642M -54.66M
Cash From Financing Activities 38.16M $9.594M 7.408M
Net Change In Cash 75.68M $50.31M 1.441M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $85.39M $45.36M $48.69M
Capital Expenditures -$6.581M -$2.589M
Free Cash Flow $91.97M $51.28M
YoY Change -1713.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001818502
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39550
dei Entity Registrant Name
EntityRegistrantName
OppFi Inc.
CY2021Q2 us-gaap Cash
Cash
311216
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
fgna Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days Before Sending Notice Of Redemption Of Warrants
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDaysBeforeSendingNoticeOfRedemptionOfWarrants
P20D
fgna Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
P3D
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Address Country
EntityAddressCountry
IL
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1648122
dei Entity Address Address Line1
EntityAddressAddressLine1
130 E. Randolph Street, Suite 3400
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60601
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
212 8079
dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
FG New America Acquisition Corp.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
39441286
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
22436103
CY2021Q2 us-gaap Liabilities
Liabilities
40981531
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
135648
CY2020Q4 us-gaap Cash
Cash
1137685
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
116734
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
228465
CY2021Q2 us-gaap Assets Current
AssetsCurrent
427950
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1366150
CY2021Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
243381069
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
243380833
CY2021Q2 us-gaap Assets
Assets
243809019
CY2020Q4 us-gaap Assets
Assets
244746983
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1540245
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
135648
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1540245
CY2020Q4 us-gaap Liabilities
Liabilities
22571751
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
197827478
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
217175222
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32385107
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13037552
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27386194
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8038450
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243809019
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244746983
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
543637
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2354632
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-543637
us-gaap Operating Income Loss
OperatingIncomeLoss
-2354632
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15724159
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17005183
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
6069
us-gaap Investment Income Net
InvestmentIncomeNet
12071
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15718090
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16993112
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16261727
us-gaap Net Income Loss
NetIncomeLoss
-19347744
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10974550
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10974550
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.76
fgna Excludes Aggregate Of Shares Subject To Possible Redemption
ExcludesAggregateOfSharesSubjectToPossibleRedemption
19325575
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-826233
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
236
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3086017
CY2021Q1 fgna Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
3086017
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16261727
CY2021Q2 fgna Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
16261727
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
us-gaap Profit Loss
ProfitLoss
-19347744
CY2020Q2 us-gaap Profit Loss
ProfitLoss
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17005183
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-111731
CY2020Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1404597
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0
CY2020Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-236
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-826469
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137685
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311216
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
fgna Tax Receivable Agreement Percentage Of Income Tax Savings Realized
TaxReceivableAgreementPercentageOfIncomeTaxSavingsRealized
0.90
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q2 fgna Investment Income Interests
InvestmentIncomeInterests
11835
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16261727
us-gaap Net Income Loss
NetIncomeLoss
-19347744
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10974550
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10974550
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.76
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2020Q4 fgna Class Of Warrant Or Right Price Of Warrants Or Rights
ClassOfWarrantOrRightPriceOfWarrantsOrRights
15
CY2020Q4 fgna Additional Units Issued To Underwriters During Period Shares New Issues
AdditionalUnitsIssuedToUnderwritersDuringPeriodSharesNewIssues
118875
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
fgna Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
P30D
fgna Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
P30D
fgna Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
18.00

Files In Submission

Name View Source Status
0001104659-21-102860-index-headers.html Edgar Link pending
0001104659-21-102860-index.html Edgar Link pending
0001104659-21-102860.txt Edgar Link pending
0001104659-21-102860-xbrl.zip Edgar Link pending
fgna-20210630.xsd Edgar Link pending
fgna-20210630x10q.htm Edgar Link pending
fgna-20210630x10q_htm.xml Edgar Link completed
fgna-20210630xex10d3.htm Edgar Link pending
fgna-20210630xex31d1.htm Edgar Link pending
fgna-20210630xex31d2.htm Edgar Link pending
fgna-20210630xex32d1.htm Edgar Link pending
fgna-20210630xex32d2.htm Edgar Link pending
fgna-20210630_cal.xml Edgar Link unprocessable
fgna-20210630_def.xml Edgar Link unprocessable
fgna-20210630_lab.xml Edgar Link unprocessable
fgna-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending